Biology of the scleroderma fibroblast

Current Opinion in Rheumatology

Volumn 10, Issue 6, 1998, Pages 572-578

  Strehlow, David ^a   Korn, Joseph H ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; FIBRILLIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SP1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

BIOLOGY; BIOSYNTHESIS; COLLAGEN METABOLISM; ENDOTHELIUM CELL; ENVIRONMENTAL FACTOR; FIBROBLAST; GENETIC LINKAGE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW; SCLERODERMA;

ANIMALS; APOPTOSIS; COLLAGEN; EXTRACELLULAR MATRIX; FIBROBLASTS; HUMANS; MICROFILAMENT PROTEINS; SCLERODERMA, SYSTEMIC; TRANSCRIPTION, GENETIC;

EID: 0031736547     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-199811000-00011     Document Type: Review

References (49)

1. Vuorio TK, Kahari VM, Lehtonen A, Vuorio EI: Fibroblast activation in scleroderma. Scandi J Rheumatol 1984, 13:229-237.
2. Kasturi KN, Hatakeyama A, Murai C, Gordon R, Phelps RG, Bona CA: B-cell deficiency does not abrogate development of cutaneous hyperplasia in mice inheriting the defective fibrillin-1 gene. J Autoimmun 1997, 10:505-517. Demonstrating that Tsk mutant mice develop thick skin even in the absence of B cells.
3. Denton CP, Xu S, Black CM, Pearson JD: Scleroderma fibroblasts show increased responsiveness to endothelial cell-derived IL-1 and bFGF. J Invest Dermatol 1997, 108:269-274. This study begins to define factors secreted from endothelial cells, perhaps including interleukin-1 and basic fibroblast growth factor, that modulate fibroblast properties and are preferentially active on scleroderma fibroblasts.
4. Serpier H, Gillery P, Salmon-Ehr V, Garnotel R, Georges N, Kalis B, Maquart FX: Antagonistic effects of interferon-gamma and interleukin-4 on fibroblast cultures. J Invest Dermatol 1997, 109:158-162. Demonstrates a reduction in interleukin-4 receptor caused by interferon-gamma.
5. Kawakami T, Ihn H, Xu W, Smith E, LeRoy C, Trojanowska M: Increased expression of TGF-beta receptors by scleroderma fibroblasts: evidence for contribution of autocrine TGF-beta signaling to scleroderma phenotype. J Invest Dermatol 1998, 110:47-51. The authors found TGF-β receptors to be more highly expressed on scleroderma fibroblasts. This may explain the differentials response of normal and scleroderma fibroblasts to TGF.
6. Jelaska A, Korn JH: Anti-Fas induces apoptosis and proliferation in human dermal fibroblasts: differences between foreskin and adult fibroblasts. J Cell Physiol 1998, 175:19-29. Adult dermal and newborn foreskin fibroblasts respond differentially to agents that induce programmed cell death, suggesting a correlation between cell age and capacity to undergo apoptosis.
7. Fluck J, Querfeld C, Cremer A, Niland S, Krieg T, Sollberg S: Normal human primary fibroblasts undergo apoptosis in three-dimensional contractile collagen gels. J Invest Dermatol 1998, 110:153-157. In the absence of artificial agents that induce apoptosis, normal dermal fibroblasts will not undergo programmed cell death in plastic culture dishes unless they are growing on a collagen matrix. The collagen lattice must be contractile, as anchored lattices do not work.
8. Duncan MR, Hasan A, Berman B: Oncostatin M stimulates collagen and glycosaminoglycan production by cultured normal dermal fibroblasts: insensitivity of sclerodermal and keloidal fibroblasts. J Invest Dermatol 1995, 104:128-133.
9. Lee KS, Ro YJ, Ryoo YW, Kwon HJ, Song JY: Regulation of interleukin-4 on collagen gene expression by systemic sclerosis fibroblasts in culture. J Dermatol Sci 1996, 12:110-117.
10. Kikuchi K, Hartl CW, Smith EA, LeRoy EC, Trojanowska M: Direct demonstration of transcriptional activation of collagen gene expression in systemic sclerosis fibroblasts: insensitivity to TGF beta 1 stimulation. Biochem Biophys Res Commun 1992, 187:45-50.
11. Kikuchi K, Kadono T, Furue M, Tamaki K: Tissue inhibitor of metalloproteinase 1 (TIMP-1) may be an autocrine growth factor in scleroderma fibroblasts. J Invest Dermatol 1997, 108:281-284. Scleroderma fibroblasts are significantly more responsive to exogenously supplied TIMP-1 than normal fibroblasts.
12. Denton CP, Xu S, Welsh KI, Pearson JD, Black CM: Scleroderma fibroblast phenotype is modulated by endothelial cell co-culture. J Rheumatol 1996, 23:633-638.
13. Gillery P, Serpier H, Polette M, Bellon G, Clavel C, Wegrowski Y, Birembaut P, Kalis B, Cariou R, Maquart FX: Gamma-interferon inhibits extracellular matrix synthesis and remodeling in collagen lattice cultures of normal and scleroderma skin fibroblasts. Eur J Cell Biol 1992, 57:244-253.
14. Gillery P, Fertin C, Nicolas JF, Chastang F, Kalis B, Banchereau J, Maquart FX: Interleukin-4 stimulates collagen gene expression in human fibroblast monolayer cultures. Potential role in fibrosis. FEBS Lett 1992, 302:231-234.
15. Salon-Ehr V, Serpier H, Nawrocki B, Gillery P, Clavel C, Kalis B, et al.: Expression of interleukin-4 scleroderma skin specimens and scleroderma fibroblast cultures: potential role in fibrosis. Arch Dermatol 1996, 132:802-806.
16. Makhluf HA, Stepniakowska J, Hoffman S, Smith E, LeRoy EC, Trojanowska M: IL-4 upregulates tenascin synthesis in scleroderma and healthy skin fibroblasts. J Invest Dermatol 1996, 107:856-859.
17. Famularo G, Procopio A, Giacomelli R, Danese C, Sacchetti S, Perego MA, et al.: Soluble interleukin-2 receptor, interleukin-2 and interleukin-4 in sera and supernatants from patients with progressive systemic sclerosis. Clin Exp Immunol 1990, 81:368-372.
18. Needleman BW, Wigley FM, Stair RW: Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor alpha, and interferon-gamma levels in sera from patients with scleroderma. Arthritis Rheum 1992, 35:67-72.
19. Bona CA, Murai C, Casares S, Kasturi K, Nishimura H, Honjo T, Matsuda F: Structure of the mutant fibrillin-1 gene in the tight skin (TSK) mouse. DNA Res 1997, 4:267-271. This paper and the reference by Siracusa et al. (Genome Res 1996, 6:300-313) define the structure of the mutation in the tsk mouse likely to be responsible for the defect.
20. Siracusa LD, McGrath R, Ma Q, Moskow JJ, Manne J, Christner PJ, et al.: A tandem duplication within the fibrillin 1 gene is associated with the mouse tight skin mutation. Genome Res 1996, 6:300-313. This paper and the reference by Bona et al. (DNA Res 1997, 4:267-271). define the structure of the mutation in the tsk mouse likely to be responsible for the defect.
21. Jimenez SA, Christner P: Animal models of systemic sclerosis. Clin Dermatol 1994, 12:425-436.
22. Arnett FC, Howard RF, Tan F, Moulds JM, Bias WB, Durban E, et al.: Increased prevalence of systemic sclerosis in a Native American tribe in Oklahoma. Association with an Amerindian HLA haplotype. Arthritis Rheum 1996, 39:1362-1370.
23. Tan FK, Stivers DN, Foster MW, Chakraborty R, Howard RF, Milewicz DM, Arnett FC: Microsatellite markers flanking the fibrillin-1 gene on human chromosome 15q are associated with scleroderma in a Native American population. Arthritis Rheum 1997, 40:S73.
24. Pablos JL, Everett ET, Harley R, LeRoy EC, Norris JS: Transforming growth factor-beta 1 and collagen gene expression during postnatal skin development and fibrosis in the tight-skin mouse. Lab Invest 1995, 72:670-678.
25. Jelaska A, Korn JH: Apoptosis as a selection factor in the pathogenesis of scleroderma. Arthritis Rheum 1997, 40:S200.
26. Li L, Artlett CM, Jimenez SA, Hall DJ, Varga J: Positive regulation of human alpha 1 (I) collagen promoter activity by transcription factor Sp1. Gene 1995, 164:229-234.
27. Tamaki T, Ohnishi K, Hartl C, LeRoy EC, Trojanowska M: Characterization of a GC-rich region containing Sp1 binding site(s) as a constitutive responsive element of the alpha 2(I) collagen gene in human fibroblasts. J Biol Chem 1995, 270:4299-4304.
28. Ihn H, Ohnishi K, Tamaki T, LeRoy EC, Trojanowska M: Transcriptional regulation of the human alpha2(I) collagen gene: combined action of upstream stimulatory and inhibitory cis-acting elements. J Biol Chem. 1996, 271:26717-26723.
29. Hasegawa T, Zhou X, Garrett LA, Ruteshouser EC, Maity SN, de Crombrugghe B: Evidence for three major transcription activation elements in the proximal mouse proalpha2(I) collagen promoter. Nucleic Acids Res 1996, 24:3253-3260.
30. Greenwel P, Inagaki Y, Hu W, Walsh M, Ramirez F: Sp1 is required for the early response of alpha2(I) collagen to transforming growth factor-beta1. J Biol Chem 1997, 272:19738-19745.
31. Ihn H, LeRoy EC, Trojanowska M: Oncostatin M stimulates transcription of the human alpha2(I) collagen gene via the Sp1/Sp3-binding site. J Biol Chem 1997, 272:24666-24672. Defines a role of Sp3, normally thought to be a transcriptional repressor, as an activator of transcription of the collagen α2(I) gene.
32. Ihn H, Trojanowska M: Sp3 is a transcriptional activator of the human alpha2(I) collagen gene. Nucleic Acids Res 1997, 25:3712-3717. This study presents further evidence for a role of Sp3 in regulating collagen transcription.
33. Galera P, Park RW, Ducy P, Mattei MG, Karsenty G: c-Krox binds to several sites in the promoter of both mouse type I collagen genes: structure/function study and developmental expression analysis. J Biol Chem 1996, 271:21331-21339.
34. Widom RL, Culic I, Lee JY, Korn JH: Cloning and characterization of hcKrox, a transcriptional regulator of extracellular matrix gene expression. Gene 1997, 198:407-420. This study demonstrates that the human zinc-finger-containing transcription factor c-krox functions as a transcriptional repressor of the α1(I) collagen promoter.
35. Schmitt-Graff A, Desmouliere A, Gabbiani G: Heterogeneity of myofibroblast phenotypic features: an example of fibroblastic cell plasticity. Virchows Arch 1994, 425:3-24.
36. Kirk TZ, Mark ME, Chua CC, Chua BH, Mayes MD: Myofibroblasts from scleroderma skin synthesize elevated levels of collagen and tissue inhibitor of metalloproteinase (TIMP-1) with two forms of TIMP-1. J Biol Chem 1995, 270:3423-3428.
37. Unemori EN, Amento EP: Connective tissue metabolism in scleroderma, including cytokines. Curr Opin Rheumatol 1996, 8:580-584.
38. Langholz O, Roeckel D, Petersohn D, Broermann E, Eckes B, Krieg T: Cell-matrix interactions induce tyrosine phosphorylation of MAP kinases ERK1 and ERK2 and PLCgamma-1 in two-dimensional and three-dimensional cultures of human fibroblasts. Exp Cell Res 1997, 235:22-27.
39. 1 subunit, serve as the collagen receptor.
40. Eckes B, Mauch C, Huppe G, Krieg T: Differential regulation of transcription and transcript stability of pro-alpha 1(I) collagen and fibronectin in activated fibroblasts derived from patients with systemic scleroderma. Biochem J 1996, 315:549-554. This work demonstrates that the increased steady state level of collagen mRNA is due to a combination of both increased transcription rate and increased transcript stability in scleroderma fibroblasts relative to healthy cells.
41. Langholz O, Rockel D, Mauch C, Kozlowska E, Bank I, Krieg T, Eckes B: Collagen and collagenase gene expression in three-dimensional collagen lattices are differentially regulated by alpha 1 beta 1 and alpha 2 beta 1 integrins. J Cell Biol 1995, 131:1903-1915.
42. Xu J, Clark RA: Extracellular matrix alters PDGF regulation of fibroblast integrins. J Cell Biol 1996, 132:239-249.
43. Xu J, Clark RA: A three-dimensional collagen lattice induces protein kinase C-zeta activity: role in alpha2 integrin and collagenase mRNA expression. J Cell Biol 1997, 136:473-483.
44. Xu J, Zutter MM, Santoro SA, Clark RA: A three-dimensional collagen lattice activates NF-kappaB in human fibroblasts: role in integrin alpha2 gene expression and tissue remodeling. J Cell Biol 1998, 140:709-719.
45. Jelaska A, Arakawa M, Broketa G, Korn JH: Heterogeneity of collagen synthesis in normal and systemic sclerosis skin fibroblasts: increased proportion of high collagen-producing cells in systemic sclerosis fibroblasts. Arthritis Rheum 1996, 39:1338-1346.
46. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, et al.: Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci U S A 1992, 89:10114-10118.
47. Harley CB, Futcher AB, Greider CW: Telomeres shorten during ageing of human fibroblasts. Nature 1990, 345:458-460.
48. Artlett CM, Black CM, Briggs DC, Stevens CO, Welsh KI: Telomere reduction in scleroderma patients: a possible cause for chromosomal instability. Br J Rheumatol 1996, 35:732-737.
49. Housset E, Emerit I, Baulon A, DeGrouchy J: Anomalies chromosomiques dans Ia sclerodermie generalisee. Etude de dix malades. C R Acad Sci (Paris) 1969, 269:413.